In breathless press releases and posts, the company has touted its models’ ability to deliver scientific breakthroughs. But its IPO filing taps the brakes on just how fast its AI will lead to big discoveries.
This week on “Uncanny Valley,” we go behind the scenes of our Nathan Fielder cover story, unpack tech billionaires’ generous promises, and discuss the suspicious letters sent to US election offices.
The DNA inside our cells isn’t just a series of instructions, but something far more dynamic. Like scientists, AI models don’t yet have the data to properly decode it.
Henri Kagan and Kensō Soai designed chemical reactions producing only one of the two mirror-image forms of a molecule—an important finding for the synthesis of pharmaceuticals and other biological substances.
Bridge Neurotech is planning to build a wearable brain-computer interface that uses ultrasound.
In her new book on biological warfare, Annie Jacobsen didn’t even discuss AI because scientists can already warp Mother Nature to create extinction-level events.
The practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie argues its a “moral imperative” to address hereditary diseases.
“The experiments are still in the queue. The PR is already live,” says one expert.
David Baker spoke with WIRED en Español about where biological design is headed next and the great potential and risks of taking biology outside the bounds of the natural world.